期刊文献+

不同剂量氢氯噻嗪治疗原发性高血压的疗效观察 被引量:8

Observation of the therapeutic effects of different dosages of hydrochlorothiazide on essential hypertension
原文传递
导出
摘要 目的:观察两种剂量氢氯噻嗪治疗原发性高血压的疗效和安全性。方法:选择门诊1,2级高血压患者106例,随机分为两组,分别给予12.5mg和25mg的氢氯噻嗪,qd,观察8周。比较两种剂量氢氯噻嗪的降压疗效及主要生化指标。结果:(1)降压疗效:12.5mg组和25mg组氢氯噻嗪治疗前后的收缩压和舒张压都有明显下降,差异有显著性(P<0.05)。但降压幅度、总有效率差异无显著性。(2)生化指标:治疗8周后,两组患者均出现血清钾下降及血尿酸增加,但25mg氢氯噻嗪对患者的影响更明显,且出现血糖升高,与治疗前相比差异有显著性(P<0.05)。结论:每日服用12.5mg氢氯噻嗪可有效降低1,2级原发性高血压患者的血压,与25mg组相比,降压作用相当,但对生化影响及出现的不良反应较少。 OBJECTIVE To observe the therapeutic effects and the salty of two dosages regime of hydrochlorothiazide for the treatment of essential hypertension. METHODS In order to compare the therapeutic effects and the main biochemical indicators of 12.5 mg dosage with that of 25 mg dosage, 11)6 hyperpietic outpatients who belong to the first or the second level, were div id into two groups stochastically, and the two groups taking different dosage medicine once per day respectively, and then keep ing observing the gioups for 8 weeks. RESULTS ( 1 ) curative effect: the systolic pressures and the diastolic pressures of the two groups reduced obviously ajter treatment, and the reductions had statistical significance (P〈0. 05). However, both the extent of reduction and the total efficiency hadn't statistical significance. (2)biochemical indicator: After 8 weeks treatment, both groups had the decline of serum potassium and the increase of serum uric acid. but the impact of 12.5 mg dosage was more marked as well as the increase of blood sugar. Compared with the indicators before the treatment, these results had statistical significance (P〈0. 05). CONCLUSION The blood pressure of hyperpietic patient, belonging to the first or the second level, can be reduced effectively after taking 12.5 mg dosage hydrochlorothiazide everyday. Compared with the 25 mg dosage, besides the 12. 5 mg dosage has equivalent effect on reducing blood pressure, its biochemical influences and ill responses are less.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第3期229-231,共3页 Chinese Journal of Hospital Pharmacy
基金 盐城市医学科技科研课题项目(编号:YK2010042)
关键词 氢氯噻嗪 原发性高血压 疗效观察 hydrochlorothiazide essential hypertension therapeutic effect observations
  • 相关文献

参考文献10

  • 1陈灏珠.实用内科学[M]12版.北京:人民卫生出版社,2005.1746-1750.
  • 2Shah SU, Anjum S, Littler WA. Use of diuretics in cardiovascular disease : (2) hypertension[J]. Postgrad Med J. 2004,80: 271- 276.
  • 3Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alphablocker as first-step antihypertensive therapy; final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLAHT) [J]. Hypertension, 2003.42 : 239 -246.
  • 4中华人民共和国卫生部高血压联盟(中国).中国高血压防治指南(2005年修订版)[M].北京,人民卫生出版社,2006:7.
  • 5吴寿岭,孙丽霞,赵海燕,王桂玲,李云,王黎光,贺文昌,刘福山,刘克俭.长期小剂量氢氯噻嗪的降压疗效观察[J].中华心血管病杂志,2006,34(5):396-399. 被引量:33
  • 6Wright JM. Choosing a first line drug in the inanagement of elevated blood preasure: what is the evidence? 1 : Thiazide[J]. CMAJ, 2000, 163 : 57-60.
  • 7Wright JM, Lee CH, Chambers GK. Systematic review of antihypertensive therapics: does the evidence assist in choosing a first-line drug[J]. CMAJ, 1999.161:25-32.
  • 8Weir MR. Flack JM, Applegate WB. Tolerahlility, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics[J]. Am J Med. 1996,101 : 83S-92S.
  • 9王文.中国高血压防治指南(2009年基层版)[EB/OL].http://www.365heart.com.
  • 10.中国药典二部[S].,2005年版.68.

二级参考文献21

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2Luis M,Emesto L.Blood pressure control and benefits of antihypertensive therapy-doesit make a difference which agents we use? Hypertension,2002,38(Part 2):537-542.
  • 3Shah SU,Anjum S,Littler WA.Use of diuretics in cardiovascular disease:(2) hypertension.Postgrad Med J,2004,80:271-276.
  • 4Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.Diuretic versus alphablocker as first-step antihypertensive therapy:final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Hypertension,2003,42:239-246.
  • 5Psaty BM,Lumley T,Furberg CD,et al.Health outcomes associated with various antihypertensive therapies used as first-line agents:a network meta-analysis.JAMA,2003,289:2534-2544.
  • 6Wright JM.Choosing a first-line drug in the management of elevated blood pressure:what is the evidence? 1:Thiazide diuretics.CMAJ,2000,163:57-60.
  • 7Leenen FH.ALLHAT:what has it taught us so far? CMAJ,2004,171:719-720.
  • 8Weir MR,Flack JM,Applegate WB.Tolerability,safety,and quality of life and hypertensive therapy:The case for low-dose diuretics.Am J Med,1996,101:83s-92s.
  • 9Puschett JB.Diuretics and the therapy of hypertension.Am J Med Sci,2000,319:1-9.
  • 10Pollare T,Lithell H,Berne C.A Comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.N Engl J Med,1989,21:868-873.

共引文献1230

同被引文献41

  • 1谢玉兰,任利群,邹继红,李洁.安博维与安博诺对老年高血压的短期疗效比较[J].现代医学,2006,34(6):417-419. 被引量:5
  • 2吴寿岭,孙丽霞,赵海燕,王桂玲,李云,王黎光,贺文昌,刘福山,刘克俭.长期小剂量氢氯噻嗪的降压疗效观察[J].中华心血管病杂志,2006,34(5):396-399. 被引量:33
  • 3Shah SU,Anjum S,Littler WA.Use of diuretics in cardiovascular disease:(2)hypertension[J].Postgrad Med J,2004,80:271-276.
  • 4中华人民共和国卫生部高血压联盟.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2006.7.
  • 5中国药典.二部[S].2005.附录:29.
  • 6Wright JM. Choosing a first-line drug in the management of el- evated blood preasure: what is the evidence? 1: Thiazide[M] CMAJ,2000,163:57.
  • 7Wright JM,Lee CH,Chambers GK. Systematic review of anti- hypertensive therapies : does the evidence assist in choosing a first-line drug[J]. CMAJ, 19 9 9,161 : 2 5.
  • 8Weir MR, Flack JM, applegate WB. Tolerablility, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics[J]. Am Jmed. 1996, 101 : 83.
  • 9王文.巾国高血压防治指南(2009年基层版).http://www.365heart.corn.
  • 10中华医学会心血管病学分会商血压学组.利尿荆治疗高血压的中国专家共识[J].中华商血压杂志,2011,03:217.

引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部